HRT FINANCIAL LP - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q1 2022$150,000
+87.5%
50,617
+170.3%
0.00%
Q3 2021$80,000
-19.2%
18,724
-33.3%
0.00%
-100.0%
Q4 2020$99,000
+800.0%
28,054
+139.8%
0.00%
+100.0%
Q1 2020$11,000
-91.1%
11,700
-73.9%
0.00%
-80.0%
Q4 2019$124,00044,8920.01%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
COWEN AND COMPANY, LLC 4,331,020$7,882,0001.31%
RTW INVESTMENTS, LP 6,869,281$12,502,0000.35%
A.R.T. Advisors, LLC 14,140$26,0000.04%
Hudson Bay Capital Management LP 975,000$1,774,0000.03%
Secure Asset Management, LLC 10,000$18,0000.01%
OSAIC HOLDINGS, INC. 1,774,935$3,230,0000.01%
FNY Investment Advisers, LLC 9,900$18,0000.01%
Squarepoint Ops LLC 322,225$586,0000.01%
LMR Partners LLP 107,912$196,0000.01%
Virtu Financial LLC 17,147$31,0000.00%
View complete list of ARBUTUS BIOPHARMA CORP shareholders